New Zealand may finally get funded access to diabetes drugs which reduce cardiovascular events and progression of kidney disease: an audit of proposed PHARMAC criteria compared with international guidelines.
| Autor: | Vitz, Moritz, Moss, Bridget, Ward, Hannah, Soma, Poonam, Isichei-Kizito, Jacob, Hall, Rosemary, Krebs, Jeremy |
|---|---|
| Zdroj: | New Zealand Medical Journal; 10/9/2020, Vol. 133 Issue 1523, p76-86, 11p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|